GlassScriptPhysician profile
Olga Muldoon
NPI 1972981975
$90,751.54
in general payments reported to CMS, 2019-2025
28 companies · $27K in 2025
The $27K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.36 · 2020: $502 · 2021: $748 · 2022: $983 · 2023: $1,238 · 2024: $60K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $7,798 · Travel and Lodging: $2,562 · Gift: $48.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44,079.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,000.00 |
| Food and Beverage | $7,798.09 |
| Travel and Lodging | $2,562.00 |
| Gift | $48.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $87,907.42 | 2022-2025 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $859.16 | 2019-2021 | |
| Hologic Sales and Service, LLC | $533.05 | 2020-2025 | Acessa Provu System, Omni Hysteroscope, Myosure Tissue Removal Device |
| Coloplast Corp | $194.98 | 2022-2024 | |
| Gynesonics, INC. | $149.35 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $139.44 | 2022-2024 | Advincula Delineator Uterine Manipulator |
| Abbvie INC. | $123.18 | 2022-2024 | Botox |
| Caldera Medical, INC | $121.56 | 2020 | |
| Baxter Healthcare | $113.01 | 2025 | Tisseel |
| Ethicon US, LLC | $102.20 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.27 | 2021-2025 | |
| Channel Medsystems, INC. | $56.13 | 2022 | |
| Axonics, INC. | $37.25 | 2022 | |
| Therapeuticsmd, INC. | $33.45 | 2022 | |
| Medtronic, INC. | $31.15 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $29.87 | 2023 | |
| Astellas Pharma US INC | $25.23 | 2023 | Veozah |
| Sumitomo Pharma America, INC. | $24.85 | 2024 | Myfembree |
| Pfizer INC. | $23.04 | 2023 | |
| Olympus America INC. | $22.67 | 2024 | Olympus |
| Organon LLC | $21.98 | 2022 | |
| Minerva Surgical, INC | $21.40 | 2024 | |
| Meditrina | $21.30 | 2021 | |
| Exeltis, USA INC. | $18.46 | 2023 | Slynd |
| Exact Sciences Corporation | $16.92 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $16.38 | 2021 | |
| Innovation Technologies INC | $15.20 | 2024 | Irrisept |
| Merck Sharp & Dohme LLC | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Muldoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.